BA
CLOV icon

Ballew Advisors’s Clover Health Investments CLOV Stock Holding History

Ballew Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$43.8K Buy
+10,000
New +$44.8K 0.02% 131

Other funds holding CLOV

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
SCP
Silverleafe Capital Partners Germantown, Tennessee $351M AUM 24.63% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Ballew Advisors's CLOV Position: Q3 2026 in Review

Ballew Advisors opened a new position in Clover Health Investments (CLOV) in Q3 2026: 10,000 shares worth $43.8K. The stake represents 0.02% of the portfolio and ranks #131 among its holdings.

8 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

  • Ballew Advisors held 10,000 shares of Clover Health Investments worth $43.8K as of Q3 2026.
  • Clover Health Investments was a new Ballew Advisors position in Q3 2026.
  • Clover Health Investments made up 0.02% of Ballew Advisors's portfolio in Q3 2026, its #131 holding.
  • 8 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on Ballew Advisors's 13F filing for Q3 2026, filed 5 Oct 2026.